Looking Ahead to Less Diabetes Work: mylife Loop with CamAPS Liberty
Thriveabetes attended the mylife Diabetes Care VIP Event in Manchester on 25 and 26 July 2026.
The event brought together 15 people living with type 1 diabetes from Ireland and the UK (shoutout to Julie who joining me from Ireland). It gave us an opportunity to reconnect with familiar faces, make new connections, hear updates from the mylife Diabetes Care team, and share our own experiences and ideas.
On Saturday afternoon, we got stuck into a product update from Zara, Vicky and Katy from mylife Diabetes Care.
The update many of us were most interested in was CamAPS with Liberty, a new fully closed-loop feature being developed for the existing CamAPS FX app.
CamAPS Liberty – No Carb Counting, No meal bolus-in’
When CamAPS with Liberty is activated, users will not need to count carbohydrates or manually deliver a pre-meal insulin bolus. The CamAPS Liberty algorithm will anticipate and respond to changing glucose levels while operating within established safety limits.
It’s the world's first fully closed-loop feature. This was announced in March 2026 and progress to make it available to existing pump users is taking place at a steady pace.
This feature will mean saying goodbye to carb counting or manually delivering pre-meal boluses.
However, for the time being, Liberty is Not intended for pregnancy or for under 13s.
For people who have spent years analysing meals, estimating carbohydrates, entering information into a pump and deciding when and how much to bolus, that is a significant development.
CamAPS Liberty received EU Medical Device Regulation approval in January 2026. CamDiab announced in March that the feature would become available within CamAPS FX, with a wider rollout following an initial pilot. Its availability in individual countries remains subject to local approvals and launch arrangements.
The version discussed at the event is not currently intended for use during pregnancy or by children under 13.
Image sourced from CamAPS Liberty - CamAPS FX
The question everyone wanted answered! When?
Naturally, the question everyone wanted to ask was: When will it be available?
Well, it’s always the most difficult question to answer in the room because there are so many elements of a product release not within the control of the company.
A product can be technically ready but still require regulatory processes, local approvals, training, commercial arrangements and coordination between several organisations before it reaches users in a particular country.
The official answer from the MyLife Team remains “soon ish”.
Speaking from years of personal experience of diabetes product launches, Gráinne’s optimistic prediction is that Liberty could reach Ireland within a year.
That is very much a personal estimate rather than an official timeline. As anyone who has waited for diabetes technology to arrive in Ireland will know, there can be plenty of bumps and delays along the way.
What might it feel like to stop bolusing?
Once the formal product update had finished, we spoke with Katherine from Edinburgh, who is one of the people beta testing the Liberty feature.
She had been using it for approximately two months and described how strange it felt, and still feels, to eat without counting carbohydrates or bolusing for the meal.
That immediately made Gráinne think about all the minutes it could give back to people living with diabetes. Some of us can remember what it felt like to simply sit down and eat before diabetes became part of every meal.
Now, eating often begins with an internal calculation:
What is in this?
How many carbohydrates are there?
How much will I eat?
Is it high in fat or protein?
Should I bolus now, later or in stages?
What does my glucose level look like?
What does the pump think I need?
Even when these decisions become routine, they still take time and mental energy.
The possibility of sitting down and eating without first analysing the food, estimating its carbohydrate content and entering information into a pump is difficult to imagine.
Katherine’s experience also made the technology feel more real. This was not only a product announcement or a future concept. Someone sitting with us had already been living with it and could explain what the transition felt like in everyday life.
Unsurprisingly, we had many questions.
With 14 people living with diabetes in the room, the discussion was lively. People wanted to understand how the system responded to different meals, how it handled exercise and changing routines, and how much confidence it took to stop giving the meal boluses that had been part of diabetes management for years.
Disclosure
This was an invited event hosted by mylife Diabetes Care, which covered Thriveabetes’ travel and accommodation expenses. All views and words shared here are our own.